| Lastest Insider Transactions Of Akero Therapeutics, Inc. ( AKRO ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-11-15 | Sell | 9,061 | 27.73 | 251,274 | 2024-11-19 21:57:20 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-11-15 | Option Exercise | 9,061 | 21.10 | 191,187 | 2024-11-19 21:57:20 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-11-06 | Sell | 10,000 | 35.19 | 351,890 | 2024-11-08 17:06:12 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-11-06 | Option Exercise | 10,000 | 0.62 | 6,150 | 2024-11-08 17:06:12 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-11-01 | Sell | 50,716 | 31.57 | 1,601,252 | 2024-11-05 09:04:36 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-11-01 | Option Exercise | 40,716 | 21.09 | 858,700 | 2024-11-05 09:04:36 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-11-01 | Sell | 108,366 | 31.73 | 3,438,312 | 2024-11-05 09:00:35 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-11-01 | Option Exercise | 108,366 | 21.10 | 2,286,523 | 2024-11-05 09:00:35 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-10-30 | Sell | 20,000 | 32.60 | 651,960 | 2024-11-01 20:59:16 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-10-30 | Option Exercise | 20,000 | 21.10 | 422,000 | 2024-11-01 20:59:16 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-10-16 | Sell | 91,634 | 31.41 | 2,878,038 | 2024-10-18 20:57:33 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-10-16 | Option Exercise | 91,634 | 21.10 | 1,933,477 | 2024-10-18 20:57:33 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-10-14 | Sell | 40,000 | 30.15 | 1,206,080 | 2024-10-16 20:06:46 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-10-14 | Option Exercise | 40,000 | 21.09 | 843,600 | 2024-10-16 20:06:46 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-10-14 | Sell | 20,961 | 30.37 | 636,490 | 2024-10-16 20:06:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-10-14 | Option Exercise | 19,825 | 0.62 | 12,192 | 2024-10-16 20:06:17 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-10-01 | Sell | 10,000 | 28.18 | 281,770 | 2024-10-03 20:09:23 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-09-19 | Sell | 5,500 | 27.65 | 152,086 | 2024-09-23 18:00:05 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-09-19 | Option Exercise | 5,500 | 0.62 | 3,383 | 2024-09-23 18:00:05 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-09-16 | Sell | 8,393 | 27.54 | 231,175 | 2024-09-18 21:19:39 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-09-16 | Option Exercise | 8,393 | 0.62 | 5,162 | 2024-09-18 21:19:39 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-09-13 | Sell | 568 | 26.18 | 14,870 | 2024-09-13 17:16:02 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-09-10 | Sell | 637 | 26.18 | 16,677 | 2024-09-13 17:14:39 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-09-10 | Sell | 639 | 26.18 | 16,729 | 2024-09-13 17:13:29 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2024-09-10 | Sell | 537 | 26.18 | 14,059 | 2024-09-13 17:11:41 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-09-10 | Sell | 1,738 | 26.18 | 45,501 | 2024-09-13 17:10:03 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Sell | 14,051 | 27.52 | 386,714 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-08-23 | Option Exercise | 14,051 | 0.62 | 8,641 | 2024-08-28 11:11:17 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-08-16 | Option Exercise | 24,538 | 0.62 | 15,091 | 2024-08-20 11:45:48 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-08-01 | Sell | 5,000 | 26.75 | 133,756 | 2024-08-02 21:32:18 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-08-01 | Sell | 5,000 | 26.75 | 133,756 | 2024-08-02 21:32:18 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-08-01 | Sell | 5,000 | 26.75 | 133,756 | 2024-08-02 21:32:18 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-08-01 | Sell | 5,000 | 26.75 | 133,756 | 2024-08-02 21:32:18 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-08-01 | Sell | 5,000 | 26.75 | 133,756 | 2024-08-02 21:32:18 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-07-23 | Sell | 161,855 | 27.07 | 4,381,867 | 2024-07-25 17:54:02 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-07-23 | Option Exercise | 161,855 | 7.01 | 1,134,442 | 2024-07-25 17:54:02 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-07-16 | Sell | 34,811 | 28.05 | 976,275 | 2024-07-18 21:41:19 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-07-16 | Option Exercise | 29,803 | 7.01 | 208,889 | 2024-07-18 21:41:19 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-06-28 | Sell | 5,000 | 23.40 | 117,020 | 2024-07-02 18:55:16 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-06-11 | Sell | 2,516 | 22.64 | 56,965 | 2024-06-13 18:13:58 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-06-11 | Sell | 2,825 | 22.64 | 63,961 | 2024-06-13 18:11:17 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-06-11 | Sell | 2,831 | 22.64 | 64,094 | 2024-06-13 18:09:32 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2024-06-11 | Sell | 2,380 | 22.64 | 53,886 | 2024-06-13 18:06:46 |
| AKRO | Akero Therapeutics, Inc. | Lamy Patrick | Senior VP, Commercial Strategy | 2024-06-11 | Sell | 569 | 22.64 | 12,883 | 2024-06-13 18:04:29 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-06-11 | Sell | 7,894 | 22.64 | 178,728 | 2024-06-13 18:01:43 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-06-03 | Sell | 5,000 | 19.29 | 96,440 | 2024-06-05 17:05:34 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-05-01 | Sell | 5,000 | 20.15 | 100,750 | 2024-05-02 21:07:17 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-04-01 | Sell | 5,000 | 24.38 | 121,913 | 2024-04-03 18:55:44 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-03-13 | Sell | 723 | 28.33 | 20,483 | 2024-03-15 16:45:03 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2024-03-13 | Sell | 724 | 28.33 | 20,511 | 2024-03-15 16:44:12 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-03-13 | Sell | 1,969 | 28.33 | 55,782 | 2024-03-15 16:43:18 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-03-13 | Sell | 651 | 28.33 | 18,443 | 2024-03-15 16:42:38 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2024-03-13 | Sell | 619 | 28.33 | 17,536 | 2024-03-15 16:42:21 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-03-04 | Sell | 75,000 | 32.87 | 2,465,063 | 2024-03-06 20:14:26 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2024-03-04 | Option Exercise | 75,000 | 17.17 | 1,288,062 | 2024-03-06 20:14:26 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-03-04 | Sell | 20,646 | 35.49 | 732,727 | 2024-03-06 20:13:26 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2024-03-04 | Option Exercise | 20,646 | 13.96 | 288,124 | 2024-03-06 20:13:26 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2024-03-01 | Option Exercise | 83,321 | 0.62 | 51,242 | 2024-03-05 17:16:11 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2023-12-27 | Sell | 5,414 | 24.00 | 129,936 | 2023-12-29 20:30:36 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2023-12-27 | Option Exercise | 5,414 | 6.36 | 34,433 | 2023-12-29 20:30:36 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2023-12-14 | Sell | 597 | 20.76 | 12,394 | 2023-12-18 20:49:12 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2023-12-14 | Sell | 611 | 20.76 | 12,684 | 2023-12-18 20:40:16 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2023-12-14 | Sell | 543 | 20.76 | 11,273 | 2023-12-18 20:39:33 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-12-14 | Sell | 1,628 | 20.76 | 33,797 | 2023-12-18 20:37:09 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2023-12-14 | Sell | 514 | 20.76 | 10,671 | 2023-12-18 20:29:29 |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Directior | 2023-12-08 | Buy | 100,000 | 19.83 | 1,982,940 | 2023-12-11 21:06:30 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-12-07 | Sell | 26,978 | 20.02 | 539,969 | 2023-12-11 20:59:21 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-12-07 | Option Exercise | 26,978 | 6.36 | 171,580 | 2023-12-11 20:59:21 |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Directior | 2023-11-30 | Buy | 100,000 | 16.95 | 1,694,565 | 2023-12-05 08:37:03 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2023-11-17 | Sell | 30,000 | 14.68 | 440,259 | 2023-11-21 17:30:04 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-10-02 | Sell | 25,000 | 47.91 | 1,197,827 | 2023-10-04 20:41:21 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-10-02 | Option Exercise | 25,000 | 6.36 | 159,000 | 2023-10-04 20:41:21 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2023-10-02 | Sell | 490 | 51.10 | 25,039 | 2023-10-04 20:33:48 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2023-10-02 | Option Exercise | 490 | 21.10 | 10,339 | 2023-10-04 20:33:48 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-09-13 | Sell | 1,682 | 50.34 | 84,672 | 2023-09-25 20:36:08 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2023-09-13 | Sell | 632 | 50.34 | 31,815 | 2023-09-25 20:31:55 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2023-09-13 | Sell | 5,617 | 48.32 | 271,416 | 2023-09-25 20:31:38 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2023-09-13 | Option Exercise | 5,000 | 6.36 | 31,800 | 2023-09-25 20:31:38 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2023-09-13 | Sell | 531 | 50.34 | 26,731 | 2023-09-25 20:30:40 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2023-09-13 | Sell | 562 | 50.34 | 28,291 | 2023-09-25 20:28:46 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-09-01 | Sell | 25,000 | 49.77 | 1,244,248 | 2023-09-18 18:48:26 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-09-01 | Option Exercise | 25,000 | 6.36 | 159,000 | 2023-09-18 18:48:26 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-08-30 | Option Exercise | 15,000 | 0.62 | 9,225 | 2023-08-30 19:04:26 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2023-08-28 | Sell | 5,745 | 49.99 | 287,191 | 2023-08-30 19:04:25 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2023-08-28 | Option Exercise | 5,745 | 6.36 | 36,538 | 2023-08-30 19:04:25 |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Directior | 2023-08-08 | Buy | 25,000 | 42.06 | 1,051,475 | 2023-08-10 16:46:42 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-08-01 | Sell | 25,000 | 43.15 | 1,078,867 | 2023-08-03 16:13:00 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-08-01 | Option Exercise | 25,000 | 6.36 | 159,000 | 2023-08-03 16:13:00 |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Directior | 2023-07-28 | Buy | 55,000 | 42.95 | 2,362,234 | 2023-08-01 19:52:10 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-07-03 | Sell | 25,000 | 44.88 | 1,122,041 | 2023-07-06 20:44:20 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-07-03 | Option Exercise | 25,000 | 6.36 | 159,000 | 2023-07-06 20:44:20 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-06-27 | Option Exercise | 40,000 | 0.62 | 24,600 | 2023-06-27 19:12:06 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2023-06-21 | Sell | 33,349 | 51.74 | 1,725,390 | 2023-06-23 20:06:46 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2023-06-20 | Sell | 20,777 | 55.00 | 1,142,735 | 2023-06-22 17:20:12 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2023-06-20 | Option Exercise | 17,500 | 7.01 | 122,658 | 2023-06-22 17:20:12 |
| AKRO | Akero Therapeutics, Inc. | Heyman Tomas J. | Directior | 2023-06-16 | Sell | 26,000 | 54.67 | 1,421,529 | 2023-06-21 17:54:10 |
| AKRO | Akero Therapeutics, Inc. | Heyman Tomas J. | Directior | 2023-06-16 | Option Exercise | 26,000 | 25.04 | 651,040 | 2023-06-21 17:54:10 |
| AKRO | Akero Therapeutics, Inc. | Henderson Jane | Directior | 2023-06-16 | Sell | 40,000 | 54.17 | 2,166,685 | 2023-06-21 17:47:10 |
| AKRO | Akero Therapeutics, Inc. | Henderson Jane | Directior | 2023-06-16 | Option Exercise | 40,000 | 7.01 | 280,400 | 2023-06-21 17:47:10 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2023-06-16 | Sell | 78,200 | 54.78 | 4,284,066 | 2023-06-21 17:46:35 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2023-06-16 | Option Exercise | 40,000 | 0.61 | 24,400 | 2023-06-21 17:46:35 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2023-06-13 | Sell | 606 | 55.16 | 33,427 | 2023-06-15 21:41:50 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-06-13 | Sell | 1,613 | 55.16 | 88,973 | 2023-06-15 21:38:54 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2023-06-13 | Sell | 509 | 55.16 | 28,076 | 2023-06-15 21:35:27 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2023-06-13 | Sell | 538 | 55.16 | 29,676 | 2023-06-15 21:35:22 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2023-06-13 | Sell | 591 | 55.16 | 32,600 | 2023-06-15 21:29:09 |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Directior | 2022-09-19 | Buy | 520,000 | 29.69 | 15,440,000 | 2023-06-15 21:26:16 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-06-01 | Sell | 25,000 | 45.10 | 1,127,430 | 2023-06-05 18:23:55 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President and CEO | 2023-06-01 | Option Exercise | 25,000 | 1.46 | 36,459 | 2023-06-05 18:23:55 |
| AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Directior | 2022-09-19 | Buy | 520,000 | 29.69 | 15,440,000 | 2023-05-23 21:55:17 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-04-18 | Sell | 25,000 | 45.07 | 1,126,860 | 2023-05-03 20:28:19 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-04-18 | Option Exercise | 65,000 | 0.62 | 39,975 | 2023-05-03 20:28:19 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-04-03 | Sell | 25,000 | 37.94 | 948,576 | 2023-04-05 16:55:04 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-04-03 | Option Exercise | 25,000 | 0.62 | 15,375 | 2023-04-05 16:55:04 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-03-01 | Sell | 25,000 | 46.65 | 1,166,339 | 2023-03-03 16:21:36 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-03-01 | Option Exercise | 25,000 | 0.62 | 15,375 | 2023-03-03 16:21:36 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-02-01 | Sell | 25,000 | 49.06 | 1,226,395 | 2023-02-03 17:25:28 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-02-01 | Option Exercise | 25,000 | 0.62 | 15,375 | 2023-02-03 17:25:28 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2023-01-13 | Sell | 5,000 | 50.53 | 252,651 | 2023-01-18 17:30:32 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-01-03 | Sell | 25,000 | 51.27 | 1,281,751 | 2023-01-05 18:46:29 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2023-01-03 | Option Exercise | 25,000 | 0.62 | 15,375 | 2023-01-05 18:46:29 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2023-01-03 | Sell | 8,777 | 54.64 | 479,560 | 2023-01-05 17:56:15 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2023-01-03 | Option Exercise | 8,777 | 0.62 | 5,398 | 2023-01-05 17:56:15 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2022-12-28 | Sell | 22,016 | 50.97 | 1,122,125 | 2022-12-30 16:26:05 |
| AKRO | Akero Therapeutics, Inc. | Rolph Timothy | Chief Scientific Officer | 2022-12-28 | Option Exercise | 9,516 | 28.35 | 269,779 | 2022-12-30 16:26:05 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2022-12-27 | Sell | 20,000 | 49.77 | 995,323 | 2022-12-29 17:41:50 |
| AKRO | Akero Therapeutics, Inc. | White William Richard | Chief Financial Officer | 2022-12-27 | Option Exercise | 20,000 | 7.01 | 140,180 | 2022-12-29 17:41:50 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2022-12-27 | Sell | 12,500 | 49.57 | 619,609 | 2022-12-28 18:30:33 |
| AKRO | Akero Therapeutics, Inc. | Young Jonathan | Chief Operating Officer | 2022-12-27 | Option Exercise | 12,500 | 6.03 | 75,352 | 2022-12-28 18:30:33 |
| AKRO | Akero Therapeutics, Inc. | Cheng Andrew | President & CEO | 2022-12-16 | Option Exercise | 8,500 | 0.62 | 5,228 | 2022-12-20 19:46:56 |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | 2022-12-09 | Sell | 5,000 | 43.23 | 216,137 | 2022-12-13 20:24:50 |
